Latest Articles

Despite centuries of research into drug development, investigation into the environmental impact of pharmaceuticals is a much younger field. If not treated effectively, there is the potential for pharmaceuticals in wastewater to affect the agricultural industry through the use of this contaminated water supply.

It’s becoming increasingly apparent that treatments for complex diseases such as cancer, neurodegenerative diseases and depression are unlikely to target a single molecule in the pathological pathway. Drug developers are turning to new ways to exploit more than one drug target at a time.

A key statistical test in research fields including biology, economics and psychology, Analysis of Variance (ANOVA) is very useful for analyzing datasets. Here, we summarize the key differences between these two tests.

To combat harmful pathogens it is vitally important that scientists have facilities available that enable them to work on them safely. These facilities should prevent the operator from becoming infected with the agent they are working with and prevent the organism from escaping the laboratory setting and potentially initiating new outbreaks of disease.

How can quality control efforts keep up with the rapid advances in cellular model research? Read on for insights into challenges in recognizing and managing issues in cell culture quality control.

Prevention and detection of harmful microorganisms within the food industry, be it in your own kitchen, during the production chain or right back at the producer is imperative to keeping consumers healthy. Changes occurring in our climate are also causing shifts in the niches inhabited by microbes, and scientists must keep ahead of the game to prevent emerging issues.

Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) is a powerful analytical mass spectrometry technique that has generated numerous diagnostic and clinical applications, especially for the identification of microorganisms for medical diagnosis. Here we take a look at the role of MALDI-TOF in clinical microbial identification and what its future looks like.

Lets take a look at the science behind the gesture

Professor Shiranee Sriskandan is a Clinical Professor of Infectious Diseases at Imperial College London. She leads a team focused on the mechanisms by which streptococcal infections cause serious disease. As well as her research work, Professor Sriskandan undertakes teaching within the University and is also a medic at Hammersmith Hospital.

This article highlights the types of vaccine, trends in developing future vaccines and discusses new delivery methods and strategies to help advance our understanding of the immune system.